AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28671307 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylcholine iontophoresis in SCI subgroups
Number of subjects: 62
Study 28671307 — intervention group
Group type: EXPERIMENTAL
Intervention: Net insulin response (NetIns) in IS cohorts (ABIS and SCIS)
Number of subjects: 62
Study 28671307 — intervention group
Group type: COMPARATOR
Intervention: Placebo iontophoresis
Number of subjects: 62
Study 25837184 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem (multimodal analgesia + zolpidem)
Number of subjects: 78
Study 25837184 — intervention group
Group type: COMPARATOR
Intervention: Control (multimodal analgesia)
Number of subjects: 78
Study 23256927 — intervention group
Group type: EXPERIMENTAL
Intervention: Ownership of alcohol-branded merchandise (ABM)
Number of subjects: 1734
Study 23256927 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to alcohol brands in movies
Number of subjects: 1734
Study 23256927 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer drinking and sensation seeking
Number of subjects: 1734
Study 23256927 — intervention group
Group type: EXPERIMENTAL
Intervention: Marketing-specific cognitions (drinker identity and favorite brand to drink)
Number of subjects: 1734
Study 23256927 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-day binge drinking
Number of subjects: 1734
Study 21473979 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventricular tachycardia/fibrillation (VT/VF)
Number of subjects: 5259
Study 21473979 — intervention group
Group type: COMPARATOR
Intervention: No VT/VF
Number of subjects: 5259
Study 21473979 — intervention group
Group type: EXPERIMENTAL
Intervention: Early and late VT/VF
Number of subjects: 5259
Study 19953902 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-beta
Number of subjects: 3115
Study 23439596 — intervention group
Group type: EXPERIMENTAL
Intervention: L‐NMMA (NOS inhibitor)
Number of subjects: 18
Study 23439596 — intervention group
Group type: COMPARATOR
Intervention: Phenylephrine
Number of subjects: 18
Study 23439596 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 15987284 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacalcitol ointment (4 microg/g) applied once daily for 2 months
Number of subjects: 556
Study 12962951 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolterodine extended release 4 mg once daily
Number of subjects: 772
Study 12962951 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 772
Study 10543293 — intervention group
Group type: EXPERIMENTAL
Intervention: Home i.v. antibiotic treatment (HIVAT, 14 days)
Number of subjects: 10
Study 10543293 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled amiloride (14 days)
Number of subjects: 10
Study 10543293 — intervention group
Group type: COMPARATOR
Intervention: Placebo (14 days)
Number of subjects: 10
Study 7818568 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenidap (120 mg/day)
Number of subjects: 49
Study 7818568 — intervention group
Group type: COMPARATOR
Intervention: Piroxicam (20 mg/day)
Number of subjects: 49
Study 2678231 — intervention group
Group type: EXPERIMENTAL
Intervention: Iopromide
Number of subjects: 50
Study 2678231 — intervention group
Group type: COMPARATOR
Intervention: Amidotrizoate
Number of subjects: 50
Study 713434 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinofedrine (0.12‐‐0.17 mg/kg bodyweight)
Number of subjects: 45
Study 30175433 — intervention group
Group type: EXPERIMENTAL
Intervention: Hamilton‐T1 mechanical ventilator
Number of subjects: 30
Study 30175433 — intervention group
Group type: COMPARATOR
Intervention: Self‐inflating resuscitator
Number of subjects: 30
Study 30175433 — intervention group
Group type: COMPARATOR
Intervention: Flow‐inflating resuscitator
Number of subjects: 30
Study 30175433 — intervention group
Group type: COMPARATOR
Intervention: LTV 1200 mechanical ventilator
Number of subjects: 30
Study 27622693 — intervention group
Group type: EXPERIMENTAL
Intervention: Force-limiting instrument
Number of subjects: 12
Study 27622693 — intervention group
Group type: COMPARATOR
Intervention: Standard instrument
Number of subjects: 12
Study 24287284 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.8 g/day esterified plant sterols and stanols
Number of subjects: 30
Study 24287284 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 22396408 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior probability manipulation
Number of subjects: 0
Study 22396408 — intervention group
Group type: EXPERIMENTAL
Intervention: Potential payoff manipulation
Number of subjects: 0
Study 20350253 — intervention group
Group type: EXPERIMENTAL
Intervention: Xuezhikang (0.6 g twice daily)
Number of subjects: 2704
Study 20350253 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2704
Study 18304665 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine hydrochloride
Number of subjects: 0
Study 18304665 — intervention group
Group type: COMPARATOR
Intervention: Unmedicated AD/HD children (control group)
Number of subjects: 0
Study 16088423 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative hospital stay of 2 days
Number of subjects: 238
Study 16088423 — intervention group
Group type: COMPARATOR
Intervention: Postoperative hospital stay longer than 2 days (Control)
Number of subjects: 238
Study 12184518 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially hydrolyzed guar gum (PHGG) 5 g/day
Number of subjects: 188
Study 12184518 — intervention group
Group type: COMPARATOR
Intervention: Wheat bran 30 g/day
Number of subjects: 188
Study 10090192 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Sharp score (0-448 scale)
Number of subjects: 52
Study 10090192 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Larsen score (0-200 scale)
Number of subjects: 52
Study 7788147 — intervention group
Group type: EXPERIMENTAL
Intervention: CDP571 (10 mg/kg)
Number of subjects: 24
Study 7788147 — intervention group
Group type: EXPERIMENTAL
Intervention: CDP571 (1.0 mg/kg)
Number of subjects: 24
Study 7788147 — intervention group
Group type: EXPERIMENTAL
Intervention: CDP571 (0.1 mg/kg)
Number of subjects: 24
Study 7788147 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 2193996 — intervention group
Group type: EXPERIMENTAL
Intervention: Informed group (received patient education about drug side effects)
Number of subjects: 98
Study 2193996 — intervention group
Group type: COMPARATOR
Intervention: Uninformed group (no information about drug side effects)
Number of subjects: 98
Study 2193996 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (compliance with therapy)
Number of subjects: 98
Study 2193996 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (results of treatment)
Number of subjects: 98
Study 2193996 — intervention group
Group type: EXPERIMENTAL
Intervention: Informed group
Number of subjects: 98
Study 2193996 — intervention group
Group type: COMPARATOR
Intervention: Uninformed group
Number of subjects: 98
Study 84951 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipyrine (phenazone) treatment of mothers from the 38th week of pregnancy
Number of subjects: 48
Study 31268524 — intervention group
Group type: EXPERIMENTAL
Intervention: BrightBrainer Virtual Rehabilitation (BBVR) system
Number of subjects: 21
Study 31298333 — intervention group
Group type: EXPERIMENTAL
Intervention: Knockdown of AB073614
Number of subjects: 0
Study 31298333 — intervention group
Group type: EXPERIMENTAL
Intervention: Overexpression of AB073614
Number of subjects: 0
Study 31298333 — intervention group
Group type: EXPERIMENTAL
Intervention: Expression of AB073614 in NSCLC tissues
Number of subjects: 0
Study 28922968 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (2400 mg)
Number of subjects: 48
Study 28922968 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 25385207 — intervention group
Group type: EXPERIMENTAL
Intervention: Teamwork approaches with incremental delegation of non-clinical tasks away from physicians.
Number of subjects: 63
Study 25385207 — intervention group
Group type: EXPERIMENTAL
Intervention: Team 'huddles' guided by pre-visit planning.
Number of subjects: 63
Study 25385207 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclusion of nurse care managers in care plan design and execution.
Number of subjects: 63
Study 25385207 — intervention group
Group type: EXPERIMENTAL
Intervention: Desire for on-site teamwork training for key team members.
Number of subjects: 63
Study 23815692 — intervention group
Group type: EXPERIMENTAL
Intervention: Lecture plus live demonstration
Number of subjects: 26
Study 23815692 — intervention group
Group type: COMPARATOR
Intervention: Traditional lecture
Number of subjects: 26
Study 21387175 — intervention group
Group type: EXPERIMENTAL
Intervention: DHS (dynamic hip system screw)
Number of subjects: 335
Study 21387175 — intervention group
Group type: EXPERIMENTAL
Intervention: DHS blade (dynamic hip system blade)
Number of subjects: 335
Study 21387175 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamma3 Trochanteric Nail
Number of subjects: 335
Study 21387175 — intervention group
Group type: EXPERIMENTAL
Intervention: PFNA (proximal femoral nail antirotation)
Number of subjects: 335
Study 21387175 — intervention group
Group type: COMPARATOR
Intervention: Screw group (DHS and Gamma nail)
Number of subjects: 335
Study 21387175 — intervention group
Group type: COMPARATOR
Intervention: Blade group (DHS blade and PFNA)
Number of subjects: 335
Study 19424709 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive approach (modification of the Hardinge‐approach)
Number of subjects: 51
Study 19424709 — intervention group
Group type: COMPARATOR
Intervention: Classical lateral approach
Number of subjects: 51
Study 16751162 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 5 microg/kg
Number of subjects: 24
Study 16751162 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intrathecal morphine)
Number of subjects: 24
Study 15244198 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic hepatitis C patients with steatosis (n=23)
Number of subjects: 31
Study 15244198 — intervention group
Group type: COMPARATOR
Intervention: Chronic hepatitis C patients without steatosis (n=8)
Number of subjects: 31
Study 11074738 — intervention group
Group type: EXPERIMENTAL
Intervention: Androstenedione (200 mg/d)
Number of subjects: 50
Study 11074738 — intervention group
Group type: EXPERIMENTAL
Intervention: Androstenediol (200 mg/d)
Number of subjects: 50
Study 11074738 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 8873543 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.4% desflurane directed to the upper airway
Number of subjects: 38
Study 8873543 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.4% desflurane directed to the lower airway
Number of subjects: 38
Study 8873543 — intervention group
Group type: COMPARATOR
Intervention: 2.4% isoflurane directed to the upper airway
Number of subjects: 38
Study 8873543 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.4% isoflurane directed to the lower airway
Number of subjects: 38
Study 8873543 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased desflurane concentration in one lung (11%) while decreasing in the opposite lung (0%)
Number of subjects: 38
Study 8873543 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous administration of desflurane to both lungs
Number of subjects: 38
Study 8873543 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical and nebulized lidocaine, glossopharyngeal and superior laryngeal nerve blocks, transtracheal administration of lidocaine
Number of subjects: 38
Study 8873543 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 38
Study 8873543 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic infusions of 2% lidocaine
Number of subjects: 38
Study 1527687 — intervention group
Group type: EXPERIMENTAL
Intervention: e‐PTFE barrier membrane
Number of subjects: 11
Study 1527687 — intervention group
Group type: COMPARATOR
Intervention: FDDMA barrier
Number of subjects: 11
Study 4016786 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin plus tamoxifen (MT)
Number of subjects: 130
Study 4016786 — intervention group
Group type: EXPERIMENTAL
Intervention: MT plus fluoxymesterone
Number of subjects: 130
Study 31551218 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint massage combined with acupoint application before LC surgery
Number of subjects: 0
Study 31551218 — intervention group
Group type: COMPARATOR
Intervention: Control group (directly receive LC surgery)
Number of subjects: 0
Study 29032225 — intervention group
Group type: EXPERIMENTAL
Intervention: Right Ventricular Dysfunction (RVD) identified by elevated central venous pressure (CVP), elevated CVP-pulmonary capillary wedge pressure (PCWP) ratio, decreased pulmonary artery pulsatility index, and decreased right ventricular stroke work index.
Number of subjects: 397
Study 29032225 — intervention group
Group type: EXPERIMENTAL
Intervention: RR-RVF criteria requiring percutaneous mechanical circulatory support, including elevated CVP and CVP/PCWP and a low cardiac index despite ≥1 inotrope or vasopressor.
Number of subjects: 397
Study 26746903 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral for a post discharge medicines use review (MUR) with their regular community pharmacist
Number of subjects: 60
Study 26746903 — intervention group
Group type: COMPARATOR
Intervention: Standard discharge care
Number of subjects: 60
Study 25348087 — intervention group
Group type: EXPERIMENTAL
Intervention: HA/CMC powder
Number of subjects: 209
Study 25348087 — intervention group
Group type: COMPARATOR
Intervention: No adhesion barrier
Number of subjects: 209
Study 22678319 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac 1 mg/kg
Number of subjects: 80
Study 22678319 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of diclofenac and ketamine (0.15 mg/kg)
Number of subjects: 80
Study 22678319 — intervention group
Group type: COMPARATOR
Intervention: Placebo (100-mL isotonic saline)
Number of subjects: 80
Study 22678319 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.15 mg/kg)
Number of subjects: 80
Study 22678319 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac alone
Number of subjects: 80
Study 22678319 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of diclofenac and ketamine
Number of subjects: 80
Study 20656674 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone therapy
Number of subjects: 35531
Study 20656674 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone therapy (excluding RECORD trial)
Number of subjects: 35531
Study 20656674 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone therapy (alternative analysis)
Number of subjects: 35531
Study 17511331 — intervention group
Group type: EXPERIMENTAL
Intervention: Life Story Workshop (2-hour workshops once a week for 10 weeks)
Number of subjects: 33
Study 17511331 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 33
Study 15714902 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients (ECR and RA)
Number of subjects: 2
Study 15714902 — intervention group
Group type: EXPERIMENTAL
Intervention: ECR
Number of subjects: 2
Study 15714902 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 2
Study 11817768 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI) strategies with personalized feedback letter and two telephone counseling calls
Number of subjects: 269
Study 11817768 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (Control)
Number of subjects: 269
Study 10765125 — intervention group
Group type: COMPARATOR
Intervention: Combination of FU (600 mg/m2/week x 6, followed by a 2-week rest) and LV (500 mg/m2/week x 6 as a 2-hour infusion, followed by a 2-week rest) for 4 cycles (group A)
Number of subjects: 280
Study 10765125 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of FU and LV plus recombinant IFN (3 MU subcutaneously 3 times a week for 1 year) (group B)
Number of subjects: 280
Study 9116877 — intervention group
Group type: EXPERIMENTAL
Intervention: Herb A
Number of subjects: 303
Study 9116877 — intervention group
Group type: EXPERIMENTAL
Intervention: Herb B
Number of subjects: 303
Study 9116877 — intervention group
Group type: EXPERIMENTAL
Intervention: Herb C
Number of subjects: 303
Study 9116877 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Group A)
Number of subjects: 303
Study 9116877 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Group B)
Number of subjects: 303
Study 9116877 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Group C)
Number of subjects: 303
Study 9116877 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthmatic guinea pigs (Chinese herbs)
Number of subjects: 303
Study 1994661 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose diltiazem (mean dose, 329 mg/day)
Number of subjects: 201
Study 1994661 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 201
Study 6334071 — intervention group
Group type: EXPERIMENTAL
Intervention: pivmecillinam/pivampicillin
Number of subjects: 49
Study 6334071 — intervention group
Group type: COMPARATOR
Intervention: co-trimoxazole
Number of subjects: 49
Study 31569148 — intervention group
Group type: EXPERIMENTAL
Intervention: Short telomere length (TL) in early pregnancy
Number of subjects: 279
Study 31569148 — intervention group
Group type: COMPARATOR
Intervention: Longer telomere length (TL) in early pregnancy
Number of subjects: 279
Study 28904172 — intervention group
Group type: EXPERIMENTAL
Intervention: Daratumumab added to lenalidomide and dexamethasone
Number of subjects: 0
Study 28904172 — intervention group
Group type: EXPERIMENTAL
Intervention: Daratumumab added to bortezomib and dexamethasone
Number of subjects: 0
Study 28904172 — intervention group
Group type: COMPARATOR
Intervention: Control arm with lenalidomide and dexamethasone
Number of subjects: 0
Study 28904172 — intervention group
Group type: COMPARATOR
Intervention: Control arm with bortezomib and dexamethasone
Number of subjects: 0
Study 25184799 — intervention group
Group type: EXPERIMENTAL
Intervention: Single telephone call by an occupational therapist at a median of 18 days after discharge
Number of subjects: 153
Study 25184799 — intervention group
Group type: COMPARATOR
Intervention: Control group (no telephone call)
Number of subjects: 153
Study 25184799 — intervention group
Group type: EXPERIMENTAL
Intervention: Single telephone call by an occupational therapist
Number of subjects: 153
Study 23322010 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 21
Study 22025592 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate or severe TBI
Number of subjects: 729
Study 22025592 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild TBI with intracranial hemorrhage
Number of subjects: 729
Study 18434929 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral attic reconstruction (LAR) technique
Number of subjects: 25
Study 18434929 — intervention group
Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 25
Study 16516357 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentacel
Number of subjects: 433
Study 16516357 — intervention group
Group type: COMPARATOR
Intervention: Infanrix-IPV-Hib
Number of subjects: 433
Study 16516357 — intervention group
Group type: EXPERIMENTAL
Intervention: Both
Number of subjects: 433
Study 15758604 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed delivery in those up to 30 weeks
Number of subjects: 0
Study 15758604 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective fetocide of one severe IUGR fetus in midtrimester twin pregnancies
Number of subjects: 0
Study 15758604 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent absent or reversed end diastolic flow in the umbilical artery of monochorionic twins
Number of subjects: 0
Study 10789666 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visits by nurses
Number of subjects: 743
Study 9293932 — intervention group
Group type: EXPERIMENTAL
Intervention: Parks' anal retractor
Number of subjects: 20
Study 9293932 — intervention group
Group type: COMPARATOR
Intervention: No retractor
Number of subjects: 20
Study 8289096 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive multidisciplinary treatment strategy
Number of subjects: 98
Study 8289096 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 98
Study 8289096 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive multidisciplinary treatment strategy (in intermediate risk subgroup)
Number of subjects: 98
Study 3511404 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose parenteral 6-methylprednisolone (MP)
Number of subjects: 23
Study 3511404 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 2465852 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction VBM followed by radiotherapy
Number of subjects: 85
Study 2465852 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 85
Study 31157881 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month Facebook smoking cessation intervention
Number of subjects: 500
Study 31157881 — intervention group
Group type: COMPARATOR
Intervention: Referral to Smokefree.gov (control)
Number of subjects: 500
Study 29572124 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg diazepam
Number of subjects: 16
Study 29572124 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg baclofen
Number of subjects: 16
Study 29572124 — intervention group
Group type: COMPARATOR
Intervention: Single-pulse TMS
Number of subjects: 16
Study 28432745 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 3324
Study 28432745 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3324
Study 26178640 — intervention group
Group type: EXPERIMENTAL
Intervention: Text messaging program focused on improving sleep and physical activity (n=44)
Number of subjects: 116
Study 26178640 — intervention group
Group type: COMPARATOR
Intervention: Text messaging program focused on smoking cessation (n=72)
Number of subjects: 116
Study 24099601 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA/rAd5 vaccine
Number of subjects: 2504
Study 24099601 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2504
Study 21420176 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 1%
Number of subjects: 24
Study 21420176 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin 0.3%
Number of subjects: 24
Study 21420176 — intervention group
Group type: EXPERIMENTAL
Intervention: Gatifloxacin 0.3%
Number of subjects: 24
Study 21420176 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin 0.5%
Number of subjects: 24